Diagnostic Approach to Thrombocytopenia
The workup for thrombocytopenia should begin with confirmation of true thrombocytopenia through peripheral blood smear examination, followed by a systematic evaluation of potential causes including decreased production, increased destruction, sequestration, or dilution of platelets. 1
Initial Evaluation
Confirm True Thrombocytopenia
- Examine peripheral blood smear to distinguish true thrombocytopenia from pseudothrombocytopenia (which occurs in about 0.1% of adults due to platelet clumping in EDTA) 2
- If pseudothrombocytopenia is suspected, collect blood in a tube containing heparin or sodium citrate and repeat the platelet count 3
Essential Laboratory Tests
- Complete blood count with differential to confirm thrombocytopenia and evaluate other cell lines 1
- Coagulation studies including prothrombin time and activated partial thromboplastin time 1
- Review of previous platelet counts to distinguish acute from chronic thrombocytopenia 3
History and Physical Examination Focus
Key History Elements
- Bleeding symptoms (type, severity, duration) 2
- Medication use, especially heparin, quinidine/quinine, sulfonamides, alcohol, and other drugs associated with thrombocytopenia 2
- Recent transfusions 2
- Family history of thrombocytopenia 2
- Risk factors for HIV infection 2
- Comorbid conditions that may increase bleeding risk 2
- Recent surgeries, pregnancies, or hemostatic challenges 2
Physical Examination Focus
- Assess for bleeding signs (petechiae, purpura, ecchymosis, mucosal bleeding) 2
- Evaluate for hepatosplenomegaly and lymphadenopathy (splenomegaly suggests against ITP) 2
- Check for signs of infection, particularly HIV 2
- Look for evidence of autoimmune disorders (arthritis, skin rash, alopecia) 2
- Neurologic examination and funduscopic examination to establish baseline 2
Diagnostic Algorithm Based on Platelet Count
Severe Thrombocytopenia (<20 × 10⁹/L)
- Consider hospital admission for newly diagnosed patients 2
- For established diagnosis with no significant bleeding, outpatient management may be appropriate 2
- Evaluate for emergent causes requiring immediate intervention:
Moderate Thrombocytopenia (20-50 × 10⁹/L)
- Outpatient management is generally appropriate in the absence of significant bleeding 2
- Ensure expedited follow-up with a hematologist within 24-72 hours 2
Mild Thrombocytopenia (>50 × 10⁹/L)
- Generally asymptomatic; spontaneous serious bleeding is rare (<5% of patients) 2, 3
- Outpatient management with appropriate follow-up 2
Specialized Testing Based on Clinical Suspicion
For Suspected Immune Thrombocytopenia (ITP)
- HIV testing (HIV infection commonly associated with thrombocytopenia) 2, 1
- Consider bone marrow examination for:
For Suspected Heparin-Induced Thrombocytopenia
- Apply 4T score based on:
- Degree of thrombocytopenia
- Timing of platelet count fall
- Presence of thrombosis
- Other potential causes of thrombocytopenia 2
For Suspected Splenic Sequestration
- Abdominal ultrasound or CT scan to evaluate spleen size 2
Common Pitfalls to Avoid
- Failing to confirm true thrombocytopenia through peripheral blood smear examination 1
- Overlooking medication-induced thrombocytopenia (especially heparin, quinidine, sulfonamides) 2
- Performing unnecessary bone marrow examination before initiating therapy in typical cases 2
- Missing the diagnosis of heparin-induced thrombocytopenia, which can cause both thrombocytopenia and thrombosis 2
- Failing to recognize the dynamic pattern of platelet count changes, which can provide diagnostic clues (e.g., abrupt decrease 1-2 weeks after surgery suggests immunologic causes) 4
Special Considerations
- In pregnancy, measure blood pressure to rule out preeclampsia and perform liver function tests 2
- In ICU patients, consider the timing and pattern of platelet count decline:
- Gradual decline over 5-7 days suggests consumptive coagulopathy or bone marrow failure
- Abrupt decrease within 1-2 days after initial increase suggests immune-mediated causes 4
- For patients with both thrombocytopenia and thrombosis, consider antiphospholipid syndrome, heparin-induced thrombocytopenia, or thrombotic microangiopathies 3